Medline Industries Recalls Over 21,000 Medical Kits Due to Compromised Swabstick Packaging
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has voluntarily recalled 21,854 medical kits because they contain BD ChloraPrep Triple Swabsticks with potentially compromised packaging seals.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 25, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevices) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Medline Industries, LP has initiated a voluntary recall for several types of medical kits and procedure trays. The recall was prompted by a determination that the BD ChloraPrep Triple Swabsticks included within these kits may exhibit open seals on the applicator packaging. This defect could potentially compromise the sterility of the swabs used in medical procedures.
Which Products Are Affected
A total of 21,854 units are included in this recall. The affected products were distributed nationwide across the United States. The specific kits, SKUs, and lot numbers are as follows:
- UNIVERSAL KIT: SKU DT22010B, Lot 25EBC888
- VAD ACCESS KIT: SKU DT22790C, Lots 25EBO566 and 25EBD964
- PROCEDURE TRAY: SKU DYNDA2966A, Lots 25EBN178 and 25EBL624
- PEDIATRIC CENTRAL LINE SMALL: SKU DYNDC2208C, Lot 25EBC706
- PORT DRESSING KIT: SKU DYNDC3107, Lot 25EBN742
- NON STERILE DIALYSIS KIT: SKU DYNDH1029C, Lot 25EBC778
- UMBILICAL TRAY W/3.5&5FR CATH: SKU UVT1250, Lot 25EBO757
- UMBILICAL VESSEL TRAY: SKU UVT835, Lot 25FMI300
- HEMODIALYSIS TRAY: SKU VAR101HVAA, Lot 25EBE079
What You Should Do
Healthcare providers and facilities should immediately check their inventory for the affected SKU and lot numbers listed above. Medline Industries, LP is notifying customers through multiple channels, including email, fax, letter, and telephone. If you possess any of the affected kits, follow the instructions provided by the manufacturer for the return or disposal of the product. For further inquiries, contact Medline Industries, LP at their Northfield, Illinois headquarters.
Why This Matters
This recall is classified as a Class II event, indicating that the use of the affected product may cause temporary or medically reversible adverse health consequences. An open seal on a sterile applicator increases the risk of contamination and subsequent infection during clinical procedures.
Source
Information provided by the FDA under recall number Z-1330-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category